Capricor Therapeutics Inc (CAPR) — Cash Flow Quality Index
Capricor Therapeutics Inc (CAPR) has a Cash Flow Quality Index of -0.22x as of December 2017. Operating cash flow of $-2.67 Million is below net income of $12.31 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore CAPR operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Capricor Therapeutics Inc Cash Flow Quality Index (2017–2017)
Historical Cash Flow Quality Index for Capricor Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Capricor Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Capricor Therapeutics Inc (2017–2017)
Year-by-year earnings quality comparison for Capricor Therapeutics Inc. For live market cap and the full company financial profile, see market cap of Capricor Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2017 | -5.85x | $-14.23 Million | $2.43 Million | — |